Benzinga | Aug 10, 2020 07:11AM EDT

CASI Pharmaceuticals Q2 EPS $(0.09) Misses $(0.08) Estimate, Sales $2.67M Miss $3.75M Estimate

CASI Pharmaceuticals (NASDAQ:CASI) reported quarterly losses of $(0.09) per share which missed the analyst consensus estimate of $(0.08) by 12.5 percent. This is a 43.75 percent increase over losses of $(0.16) per share from the same period last year. The company reported quarterly sales of $2.67 million which missed the analyst consensus estimate of $3.75 million by 28.77 percent.